The enormous public health impact of adolescent substance use and its preventable morbidity and mortality show the need for the health care sector, including pediatricians and the medical home, to increase its capacity related to substance use prevention, detection, assessment, and intervention. The American Academy of Pediatrics published its policy statement “Substance Use Screening, Brief Intervention, and Referral to Treatment for Pediatricians” in 2011 to introduce the concepts and terminology of screening, brief intervention, and referral to treatment (SBIRT) and to offer clinical guidance about available substance use screening tools and intervention procedures. This policy statement is a revision of the 2011 SBIRT statement. An accompanying clinical report updates clinical guidance for adolescent SBIRT.
- SBIRT —
- screening, brief intervention, and referral to treatment
Substance use has an enormous direct and indirect public health impact on children and teenagers, ranging from prenatal exposure and complicated pregnancy outcomes to significant morbidity and mortality among adolescents and, over time, contributing to the development of many other health problems and substance use disorders. Pediatricians play a vital longitudinal role in the lives of adolescents and are uniquely positioned to effect change in adolescent patients’ health knowledge, behaviors, and well-being. Guidance about substance use can be provided in many forms: preventing or delaying the onset of substance use in lower-risk patients, discouraging ongoing use and reducing harm in intermediate-risk patients, and referring patients who have developed substance use disorders for potentially life-saving treatment.
The recommendations in Bright Futures: Guidelines for Health Supervision of Infants, Children, and Adolescents1 highlight the pediatrician’s unique role in addressing health behavior problems throughout adolescence. Because most adolescents (83%) have contact with a physician annually, consider physicians an authoritative source of knowledge about alcohol and drugs, and are receptive to discussing substance use, medical care encounters are tremendous opportunities for addressing substance use.2,3 The Substance Abuse and Mental Health Services Administration recommends universal screening for substance use, brief intervention, and/or referral to treatment (SBIRT) as part of routine health care.2 Adolescents are the age group at greatest risk of experiencing substance use–related acute3 and chronic4 health consequences and, as such, also are most likely to derive the greatest benefit from universal SBIRT. Specific SBIRT screening tools and intervention strategies have well-documented efficacy for adult alcohol use, but fewer studies of SBIRT efficacy have been conducted in adolescents.5–7 On the basis of a review of the limited research literature available in 2014, the US Preventive Services Task Force concluded that the evidence was insufficient to assess the efficacy of brief interventions to reduce adolescent substance use.8,9 Despite this early conclusion, the low cost of SBIRT, minimal potential for harm, and emerging study results together support the tremendous potential for a population-level benefit from even small reductions in substance use and provide sufficient basis for the incorporation of SBIRT practices into the medical care standards for adolescents. The accompanying clinical report10 contains clinical guidance for pediatricians and other clinicians who provide health care for adolescents.
The American Academy of Pediatrics recommends that pediatricians:
increase their capacity in substance use detection, assessment, and intervention; and
become familiar with adolescent SBIRT practices and their potential to be incorporated into universal screening and comprehensive care of adolescents in the medical home.
The American Academy of Pediatrics advocates for:
the strong support of continued research to determine the most effective brief intervention strategies applicable to adolescent health care,
health insurance providers to:
promote and pay for standard screening and brief intervention practices incorporated into medical home health maintenance appointments; and
ensure a standard mechanism for payment for confidential follow-up care of adolescents to receive continuity of care for substance use disorders; and
parity of access and services for adolescent mental health and substance use disorder treatment compared with general adolescent care and adult health care.
Sharon J.L. Levy, MD, MPH, FAAP
Janet F. Williams, MD, FAAP
Committee on Substance Use Prevention, 2015–2016
Sheryl A. Ryan, MD, FAAP, Chairperson
Pamela K. Gonzalez, MD, MS, FAAP
Stephen W. Patrick, MD, MPH, MS, FAAP
Joanna Quigley, MD, FAAP
Lorena Siqueira, MD, MSPH, FAAP
Leslie R. Walker, MD, FAAP
Former Committee Members
Sharon J.L. Levy, MD, MPH, FAAP
Janet F. Williams, MD, FAAP
Vivian B. Faden, PhD – National Institute of Alcohol Abuse and Alcoholism
Gregory Tau, MD, PhD – American Academy of Child and Adolescent Psychiatry
Renee Jarrett, MPH
This document is copyrighted and is property of the American Academy of Pediatrics and its Board of Directors. All authors have filed conflict of interest statements with the American Academy of Pediatrics. Any conflicts have been resolved through a process approved by the Board of Directors. The American Academy of Pediatrics has neither solicited nor accepted any commercial involvement in the development of the content of this publication.
Policy statements from the American Academy of Pediatrics benefit from expertise and resources of liaisons and internal (AAP) and external reviewers. However, policy statements from the American Academy of Pediatrics may not reflect the views of the liaisons or the organizations or government agencies that they represent.
The guidance in this statement does not indicate an exclusive course of treatment or serve as a standard of medical care. Variations, taking into account individual circumstances, may be appropriate.
All policy statements from the American Academy of Pediatrics automatically expire 5 years after publication unless reaffirmed, revised, or retired at or before that time.
FINANCIAL DISCLOSURE: The authors have indicated they do not have a financial relationship relevant to this article to disclose.
FUNDING: No external funding.
POTENTIAL CONFLICT OF INTEREST: Dr Levy has indicated she has a copyright relationship with Boston Children’s Hospital regarding the Screening to Brief Intervention (S2BI) tool.
- Hagan JF,
- Shaw JS,
- Duncan P
- Substance Abuse and Mental Health Services Administration
- Centers for Disease Control and Prevention
- Jonas DE,
- Garbutt JC,
- Halle RA, et al
- Madras BK,
- Compton WM,
- Avula D,
- Stegbauer T,
- Stein JB,
- Clark HW
- Moyer VA; US Preventive Services Task Force
- US Preventive Services Task Force
- Levy S,
- Williams JF; American Academy of Pediatrics, Committee on Substance Abuse
- Copyright © 2016 by the American Academy of Pediatrics